Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
State Street Corp reported a 5.50% stake in Iovance Biotherapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.50% stake in Iovance Biotherapeutics, Inc., 24,478,268 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 24,478,268
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 24,478,268 |
Source
Related
- Iovance Biotherapeutics, Inc.
- State Street Corp
- Iovance Biotherapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · May 12, 2026
- Schedule 13G · State Street Corp · Feb 9, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026